PROSOGAN® INJECTION Lansoprazole
... Since physiological function is generally decreased in elderly patients, PROSOGAN ® Injection 30 mg should be carefully administered. Use during Pregnancy, Delivery or Lactation 1. PROSOGAN ® Injection 30 mg should be used in pregnant women or women having possibilities of being pregnant only if the ...
... Since physiological function is generally decreased in elderly patients, PROSOGAN ® Injection 30 mg should be carefully administered. Use during Pregnancy, Delivery or Lactation 1. PROSOGAN ® Injection 30 mg should be used in pregnant women or women having possibilities of being pregnant only if the ...
MIDODRINE HYDROCHLORIDE TABLETS, 2.5 mg, 5 mg and 10 mg
... mutagenicity. Other than the dominant lethal assay in male mice, where no impairment of fertility was observed, there have been no studies on the effects of midodrine HCl on fertility. Pregnancy Pregnancy Category C Midodrine HCl increased the rate of embryo resorption, reduced fetal body weight in ...
... mutagenicity. Other than the dominant lethal assay in male mice, where no impairment of fertility was observed, there have been no studies on the effects of midodrine HCl on fertility. Pregnancy Pregnancy Category C Midodrine HCl increased the rate of embryo resorption, reduced fetal body weight in ...
Anticaog_update_R_Maclean
... daily should be considered if the patient's assessed risk for bleeding outweighs the risk for recurrent DVT and PE ...
... daily should be considered if the patient's assessed risk for bleeding outweighs the risk for recurrent DVT and PE ...
Oral Candidiasis – A Review
... drug response is the initial sign of underlying systemic disease. Follow-up appointment after 3 to 7 days is important to check the effect of drugs. Main Goals of treatment are (Parihar, 20111), 1. To identify & eliminate possible contributory factors 2. To prevent systemic dissemination 3. To elimi ...
... drug response is the initial sign of underlying systemic disease. Follow-up appointment after 3 to 7 days is important to check the effect of drugs. Main Goals of treatment are (Parihar, 20111), 1. To identify & eliminate possible contributory factors 2. To prevent systemic dissemination 3. To elimi ...
Pharmacological management of epilepsy
... The relative risks and benefits of starting or withholding antiepileptic drug treatment in patients with few or infrequent seizures are unclear.9 Marson et al. compared the policies of immediate versus deferred treatment in such patients and assessed the effects of these policies on shortterm recurr ...
... The relative risks and benefits of starting or withholding antiepileptic drug treatment in patients with few or infrequent seizures are unclear.9 Marson et al. compared the policies of immediate versus deferred treatment in such patients and assessed the effects of these policies on shortterm recurr ...
Cetrotide® 0.25 mg
... Long-term carcinogenicity studies in animals have not been performed with cetrorelix acetate. Cetrorelix acetate was not genotoxic in vitro (Ames test, HPRT test, chromosome aberration test) or in vivo (chromosome aberration test, mouse micronucleus test). Cetrorelix acetate induced polyploidy in CH ...
... Long-term carcinogenicity studies in animals have not been performed with cetrorelix acetate. Cetrorelix acetate was not genotoxic in vitro (Ames test, HPRT test, chromosome aberration test) or in vivo (chromosome aberration test, mouse micronucleus test). Cetrorelix acetate induced polyploidy in CH ...
Product Information: Dolutegravir (as sodium)
... impairment. Caution is warranted for INI-experienced patients (with certain INI-associated resistance substitutions or clinically suspected INI resistance) with severe renal impairment, as the decrease in dolutegravir concentrations may result in loss of therapeutic effect and development of resista ...
... impairment. Caution is warranted for INI-experienced patients (with certain INI-associated resistance substitutions or clinically suspected INI resistance) with severe renal impairment, as the decrease in dolutegravir concentrations may result in loss of therapeutic effect and development of resista ...
264: Treatment of Keratoconus Using Riboflavin
... The goal is for two groups of approximately 66 patients to ...
... The goal is for two groups of approximately 66 patients to ...
Yellow iron oxide (E172) 0.1875 mg
... These adverse reactions occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal. Rare cases of gastrointestinal bleeding are reported. If adverse reactions occur, use of the pr ...
... These adverse reactions occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal. Rare cases of gastrointestinal bleeding are reported. If adverse reactions occur, use of the pr ...
Cetrotide® 0.25 mg (cetrorelix acetate for injection) FOR
... When administered to rats for the first seven days of pregnancy, cetrorelix acetate did not affect the development of the implanted conceptus at doses up to 38 μg/kg (approximately 1 times the recommended human therapeutic dose based on body surface area). However, a dose of 139 μg/kg (approximately ...
... When administered to rats for the first seven days of pregnancy, cetrorelix acetate did not affect the development of the implanted conceptus at doses up to 38 μg/kg (approximately 1 times the recommended human therapeutic dose based on body surface area). However, a dose of 139 μg/kg (approximately ...
CHAPTER 12. SCHIZOPHRENIA 12.8 SCHIZOPHRENIA: SOMATIC
... clozapine's association with agranulocytosis has limited the number of patients who receive it, this agent plays an important role in the treatment of severe psychosis. The introduction of risperidone (Risperdal) in 1994, olanzapine (Zyprexa) in 1996, quetiapine (Seroquel) in 1997, and ziprasidone ( ...
... clozapine's association with agranulocytosis has limited the number of patients who receive it, this agent plays an important role in the treatment of severe psychosis. The introduction of risperidone (Risperdal) in 1994, olanzapine (Zyprexa) in 1996, quetiapine (Seroquel) in 1997, and ziprasidone ( ...
Roxycodone (oxycodone hydrochloride): prescribing
... ROXICODONE (oxycodone hydrochloride) in a progressive plan of pain management such as outlined by the World Health Organization, the Agency for Health Care Policy and Research, and the American Pain Society. Use of ROXICODONE is associated with increased potential risks and should be used only wit ...
... ROXICODONE (oxycodone hydrochloride) in a progressive plan of pain management such as outlined by the World Health Organization, the Agency for Health Care Policy and Research, and the American Pain Society. Use of ROXICODONE is associated with increased potential risks and should be used only wit ...
bevacizumab - Cancer Care Ontario
... Alternative infusion rates have been described by Mahfoud et al and Reidy et al, but these have not been approved by Health Canada Refrigerate unopened vials and protect from light; do not freeze. ...
... Alternative infusion rates have been described by Mahfoud et al and Reidy et al, but these have not been approved by Health Canada Refrigerate unopened vials and protect from light; do not freeze. ...
Rat Anesthesia and Analgesia Formulary
... Note that all of these doses are approximations and must be titrated to the animal’s strain, age, sex, health status, and individual responses. Significant departures from these doses should be discussed with a veterinarian. Doses will also vary depending on what other drugs are being administered c ...
... Note that all of these doses are approximations and must be titrated to the animal’s strain, age, sex, health status, and individual responses. Significant departures from these doses should be discussed with a veterinarian. Doses will also vary depending on what other drugs are being administered c ...
product monograph
... The safety and efficacy of NEULASTA administered concurrently with cytotoxic chemotherapy have not been established. Because of the potential for an increase in sensitivity of rapidly dividing myeloid cells to cytotoxic chemotherapy‚ NEULASTA should not be administered in the period between 14 days ...
... The safety and efficacy of NEULASTA administered concurrently with cytotoxic chemotherapy have not been established. Because of the potential for an increase in sensitivity of rapidly dividing myeloid cells to cytotoxic chemotherapy‚ NEULASTA should not be administered in the period between 14 days ...
Japanese Journal of Ophthalmology Vol.44 No.2
... Observations: In 86 patients (76.7%), phlyctenular eye disease was associated with tuberculosis. Worm infestation was found in 14 patients (12.4%), whereas 7 (6.2%) had staphylococcal blepharitis. Thirteen patients had evidence of multiple etiology, of which one causative factor was always tuberculo ...
... Observations: In 86 patients (76.7%), phlyctenular eye disease was associated with tuberculosis. Worm infestation was found in 14 patients (12.4%), whereas 7 (6.2%) had staphylococcal blepharitis. Thirteen patients had evidence of multiple etiology, of which one causative factor was always tuberculo ...
Merck drug finasteride (PROSCAR)
... renal impairment. This decrease was associated with an increase in fecal excretion of metabolites. Plasma concentrations of metabolites were significantly higher in patients with renal impairment (based on a 60% increase in total radioactivity AUC). However, finasteride has been well tolerated in BP ...
... renal impairment. This decrease was associated with an increase in fecal excretion of metabolites. Plasma concentrations of metabolites were significantly higher in patients with renal impairment (based on a 60% increase in total radioactivity AUC). However, finasteride has been well tolerated in BP ...
Treatment of acute agitation in psychotic disorders
... escalation that may result in aggressive or violent behavior. The primary goal of interventions is to secure safety of the patient, staff, and other patients. The first step in the management of aggressive patients should be talking to a patient and offering help if needed. The next step is a decisi ...
... escalation that may result in aggressive or violent behavior. The primary goal of interventions is to secure safety of the patient, staff, and other patients. The first step in the management of aggressive patients should be talking to a patient and offering help if needed. The next step is a decisi ...
Drugs Used in Tuberculosis and Leprosy
... A minor asymptomatic increase in liver aminotransferase is seen in 10 to 20% of patients, whereas fatal hepatitis is seen in fewer than 1% of isoniazid recipients. Risk factors for hepatitis include underlying liver disease, advanced age, pregnancy, and combination therapy with acetaminophen. Early ...
... A minor asymptomatic increase in liver aminotransferase is seen in 10 to 20% of patients, whereas fatal hepatitis is seen in fewer than 1% of isoniazid recipients. Risk factors for hepatitis include underlying liver disease, advanced age, pregnancy, and combination therapy with acetaminophen. Early ...
Hepatitis C Treatment
... syringe or in an autoinjector. The medication is given SQ once weekly into the abdomen or the thigh. Dosages may be modified for people with Thrombocytopenia,Leukopenia, renal insufficiency, increased ALT’s and Depression; Clinical Use: It is used in combination with Ribavirin, with or without a dir ...
... syringe or in an autoinjector. The medication is given SQ once weekly into the abdomen or the thigh. Dosages may be modified for people with Thrombocytopenia,Leukopenia, renal insufficiency, increased ALT’s and Depression; Clinical Use: It is used in combination with Ribavirin, with or without a dir ...
THE FIRST-AND-ONLY ONE DOSE IV treatment for flu
... • Patients with influenza may be at an increased risk of hallucinations, delirium and abnormal behavior early in their illness. There have been postmarketing reports (from Japan) of delirium and abnormal behavior leading to injury in patients with influenza who were receiving neuraminidase inhibito ...
... • Patients with influenza may be at an increased risk of hallucinations, delirium and abnormal behavior early in their illness. There have been postmarketing reports (from Japan) of delirium and abnormal behavior leading to injury in patients with influenza who were receiving neuraminidase inhibito ...
important drug warning
... receiving INVIRASE/ritonavir, additive effects on QT and/or PR interval prolongation may occur with certain members of the following drug classes: antiarrhythmics Class IA or Class III, neuroleptics, antidepressive agents, PDE5 inhibitors (when used for pulmonary arterial hypertension), antimicrobia ...
... receiving INVIRASE/ritonavir, additive effects on QT and/or PR interval prolongation may occur with certain members of the following drug classes: antiarrhythmics Class IA or Class III, neuroleptics, antidepressive agents, PDE5 inhibitors (when used for pulmonary arterial hypertension), antimicrobia ...
An alpha-adrenergic agonist, clonidine functions as an antagonist at
... BACKGROUND: An alpha-adrenergic agonist, clonidine functions as an antagonist at receptors on cells of the locus ceruleus (found in the primitive pons) and is widely used to treat explosive symptoms in children,1 is effective in the treatment of combat-related post-traumatic stress disorder 2 and is ...
... BACKGROUND: An alpha-adrenergic agonist, clonidine functions as an antagonist at receptors on cells of the locus ceruleus (found in the primitive pons) and is widely used to treat explosive symptoms in children,1 is effective in the treatment of combat-related post-traumatic stress disorder 2 and is ...
Corneal Ulceration - All Pets Veterinary Home Care
... and/or to prevent infections. If the ulcer is deep and there is concern about infection within the eye, then oral or injectable antibiotics may also be given. • Topical atropine (pupil dilator) or other pain medications (nalbuphine, morphine) may be given, as needed. • Topical and/or oral antiviral ...
... and/or to prevent infections. If the ulcer is deep and there is concern about infection within the eye, then oral or injectable antibiotics may also be given. • Topical atropine (pupil dilator) or other pain medications (nalbuphine, morphine) may be given, as needed. • Topical and/or oral antiviral ...
Treatment Options for Clozapine-Induced Enuresis: A
... clozapine-induced enuresis. Desmopressin was the most commonly reported effective treatment in case reports. Ephedrine was also shown to be an effective and well-tolerated treatment with a relatively rapid onset of action. The anticholinergic agents oxybutynin and trihexiphenidyl were also reported ...
... clozapine-induced enuresis. Desmopressin was the most commonly reported effective treatment in case reports. Ephedrine was also shown to be an effective and well-tolerated treatment with a relatively rapid onset of action. The anticholinergic agents oxybutynin and trihexiphenidyl were also reported ...
Ofloxacin
Ofloxacin is a synthetic antibiotic of the fluoroquinolone drug class considered to be a second-generation fluoroquinolone.Ofloxacin was first patented in 1982 (European Patent Daiichi) and received approval from the U.S. Food and Drug Administration (FDA) on December 28, 1990. Ofloxacin is sold under a wide variety of brand names as well as generic drug equivalents, for oral and intravenous administration. Ofloxacin is also available for topical use, as eye drops and ear drops (marketed as Ocuflox and Floxin Otic respectively in the United States and marketed as Optiflox, eylox respectively in Jordan and Saudi Arabia).Ofloxacin is a racemic mixture, which consists of 50% levofloxacin (the biologically active component) and 50% of its “mirror image” or enantiomer dextrofloxacin.Ofloxacin has been associated with adverse drug reactions, such as tendon damage (including spontaneous tendon ruptures) and peripheral neuropathy (which may be irreversible); tendon damage may manifest long after therapy had been completed, and, in severe cases, may result in lifelong disabilities.